Supplementation with Olive leaf extract may reduce risk factors for type 2 diabetes according to a clinical trial conducted at the University of Auckland’s Liggins institute.
The 12 week study of 46 overweight men taking four capsules as a single daily dose of olive leaf extract equating to 51.1mg Oleuropein showed improvement in insulin sensitivity.
Researchers commenting on the findings of the clinical trial said that “remarkably, the observed effects of OLE (olive leaf extract) supplementation in our study population is comparable to common diabetic therapeutics (particularly metformin), and our results could have clinical significance for patients with type 2 diabetes”.
Cabot Health’s Olive Leaf with Thyme capsules contains 31.8mg of Oleuropeins per capsule as well as Thyme and Zinc.
Read the entire clinical trial paper click on the following link;